It seems that a monthly injection could reduce the migraines people suffer from by 50%. At least this is what research presented at the American Academy of Neurology on Tuesday claims. It’s no secret that migraine sufferers are sometimes unable to live their lives because of the headaches that they have to endure. Sometimes, this throbbing pain can bring nausea, light and sound sensitivity, and even vomiting with it. Official numbers tell us that about four million Americans suffer from chronic migraines. They endure them every month and sometimes, they can even last for up to two weeks.
However, this injection, which contains the synthetic antibody called erenumab, needs to be taken every month. It promises to increase the quality of life and reduce the length of these episodes. Erenumab is so efficient because it can block the calcitonin gene-related called peptide. It is responsible for sending the pain signals to the brain and therefore, make you suffer from the migraines. Erenumab simply stops the peptide from sending that signal even before the migraine starts.
An injection could be the key to reducing migraines
It’s interesting that back in November, preliminary research was published by the New England Journal of Medicine regarding this very remedy. This targeted treatment might be a revolutionary way to treat migraines. It’s not a secret that mild migraine sufferers usually take ibuprofen. However, those suffering from stronger migraines take ergotamine and sumatripin, which are prescription drugs.
Botox is also an efficient way of stopping migraines by relaxing the muscles that might constrict. However, it’s very expensive it even has some side effects. However, it seems that this problem might finally be solved thanks to erenumab. It could offer these people an effective remedy while avoiding any unwanted and sometimes, very nasty, side effects.
Image source: flickr